Potential Doxorubicin-Mediated Dual-Targeting Chemotherapy in FANC/BRCA-Deficient Tumors via Modulation of Cellular Formaldehyde Concentration-Reference-Cited by-同舟云学术

Potential Doxorubicin-Mediated Dual-Targeting Chemotherapy in FANC/BRCA-Deficient Tumors via Modulation of Cellular Formaldehyde Concentration

Published:2020-09-02 Issue:10 Volume:33 Page:2659-2667
ISSN:0893-228X
Container-title:Chemical Research in Toxicology
language:en
Short-container-title:Chem. Res. Toxicol.

Author:

Nakamura Jun¹²^ORCID

Affiliation:

1. Laboratory of Laboratory Animal Science, Graduate School of Life and Environmental Biosciences, Osaka Prefecture University, Izumisano, Osaka 598-8531, Japan

2. Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27516, United States

Funder

Japan Society for the Promotion of Science

Ministry of Health, Labour and Welfare

Publisher

American Chemical Society (ACS)

Subject

Toxicology,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.chemrestox.0c00288

Reference76 articles.

1. Anthracyclines and ellipticines as DNA-damaging anticancer drugs: Recent advances

2. World Health Organization. 21st WHO Model List of Essential Medicines; Geneva, Switzerland, 2019.

3. Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

4. Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II

5. Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complex Interplay between DNA Damage and Autophagy in Disease and Therapy;Biomolecules;2024-07-29

2. Fanconi anemia and Aldehyde Degradation Deficiency Syndrome: Metabolism and DNA repair protect the genome and hematopoiesis from endogenous DNA damage;DNA Repair;2023-10